-
2
-
-
0024996265
-
Diabetes, fibrinogen and risk of cardiovascular disease: The Framingham experience
-
Kannel WB, D'Agostino RB, Wilson PW, et al: Diabetes, fibrinogen and risk of cardiovascular disease: The Framingham experience. Am Heart J 120:672-676, 1990
-
(1990)
Am Heart J
, vol.120
, pp. 672-676
-
-
Kannel, W.B.1
D'Agostino, R.B.2
Wilson, P.W.3
-
3
-
-
0022591979
-
The pathogenesis of atherosclerosis: An update
-
Ross R: The pathogenesis of atherosclerosis: An update. N Engl J Med 14:488-500, 1986
-
(1986)
N Engl J Med
, vol.14
, pp. 488-500
-
-
Ross, R.1
-
4
-
-
0027119951
-
Thrombosis and atherogenesis: Molecular connections
-
Nachman RL: Thrombosis and atherogenesis: Molecular connections. Blood 79:1897-1906, 1992
-
(1992)
Blood
, vol.79
, pp. 1897-1906
-
-
Nachman, R.L.1
-
5
-
-
0023270863
-
Diabetes mellitus as a hypercoagulable state: Its relationships with fibrin fragments and vascular damage
-
Garcia Frade LJ, de la Calle H, Alava I, et al: Diabetes mellitus as a hypercoagulable state: Its relationships with fibrin fragments and vascular damage. Thromb Res 47:533-540, 1987
-
(1987)
Thromb Res
, vol.47
, pp. 533-540
-
-
Garcia Frade, L.J.1
De La Calle, H.2
Alava, I.3
-
6
-
-
0023855392
-
Tissue-type plasminogen activator antigen and plasminogen activator inhibitor in diabetes mellitus
-
Auwerx J, Bouillon R, Collen D, et al: Tissue-type plasminogen activator antigen and plasminogen activator inhibitor in diabetes mellitus. Arteriosclerosis 8:68-72, 1988
-
(1988)
Arteriosclerosis
, vol.8
, pp. 68-72
-
-
Auwerx, J.1
Bouillon, R.2
Collen, D.3
-
7
-
-
0026569276
-
Effect of diabetes on the coagulation and fibrinolytic systems and its implications for atherogenesis
-
Schneider DJ, Sobel BE: Effect of diabetes on the coagulation and fibrinolytic systems and its implications for atherogenesis. Coron Artery Dis 3:26-32, 1992
-
(1992)
Coron Artery Dis
, vol.3
, pp. 26-32
-
-
Schneider, D.J.1
Sobel, B.E.2
-
8
-
-
0026480611
-
Coagulation and fibrinolytic system impairment in insulin dependent diabetes mellitus
-
Carmassi F, Morale M, Puccetti R, et al: Coagulation and fibrinolytic system impairment in insulin dependent diabetes mellitus. Thromb Res 67:643-654, 1992
-
(1992)
Thromb Res
, vol.67
, pp. 643-654
-
-
Carmassi, F.1
Morale, M.2
Puccetti, R.3
-
9
-
-
0025976627
-
Insulin resistance and compensatory hyperinsulinia; Role in hypertension, dyslipidemia and coronary heart disease
-
Reaven GM: Insulin resistance and compensatory hyperinsulinia; Role in hypertension, dyslipidemia and coronary heart disease. Am Heart J 121:1283-1288, 1991
-
(1991)
Am Heart J
, vol.121
, pp. 1283-1288
-
-
Reaven, G.M.1
-
10
-
-
0020319478
-
Insulin secretion, insulin resistance and obesity
-
De Fronzo RA: Insulin secretion, insulin resistance and obesity. Int J Obes 6:73-82, 1982
-
(1982)
Int J Obes
, vol.6
, pp. 73-82
-
-
De Fronzo, R.A.1
-
11
-
-
0028008336
-
Factors responsible for impaired fibrinolysis in obese subjects and NIDDM patients
-
McGill JB, Schneider DJ, Arfken CL, et al: Factors responsible for impaired fibrinolysis in obese subjects and NIDDM patients. Diabetes 43:104-109, 1994
-
(1994)
Diabetes
, vol.43
, pp. 104-109
-
-
McGill, J.B.1
Schneider, D.J.2
Arfken, C.L.3
-
12
-
-
0028334510
-
Evaluation of cardiovascular risk factors in overweight and obese subjects
-
Avellone G, Di Garbo V, Cordova R, et al: Evaluation of cardiovascular risk factors in overweight and obese subjects. Int Angiol 13:25-29, 1994
-
(1994)
Int Angiol
, vol.13
, pp. 25-29
-
-
Avellone, G.1
Di Garbo, V.2
Cordova, R.3
-
13
-
-
0003514455
-
Report of a WHO study group
-
Geneva, Switzerland
-
World Health Organization Expert Committee on Diabetes Mellitus: Report of a WHO study group. Geneva, Switzerland, WHO Tech Rep Ser 727, 1985
-
(1985)
WHO Tech Rep Ser
, vol.727
-
-
-
15
-
-
0021210911
-
Fibrinogen as risk factor for stroke and myocardial infarction
-
Wilhelmsen L. Svardsudd K, Korsan-Bengtsen K, et al: Fibrinogen as risk factor for stroke and myocardial infarction. N Engl J Med 311:501-505, 1984
-
(1984)
N Engl J Med
, vol.311
, pp. 501-505
-
-
Wilhelmsen, L.1
Svardsudd, K.2
Korsan-Bengtsen, K.3
-
16
-
-
0022485106
-
Haemostatic function and ischaemic heart disease: Principal results of the Northwick Park Heart Study
-
Meade TW, Mellows S, Brozovic M, et al: Haemostatic function and ischaemic heart disease: Principal results of the Northwick Park Heart Study. Lancet 11:533-537, 1986
-
(1986)
Lancet
, vol.11
, pp. 533-537
-
-
Meade, T.W.1
Mellows, S.2
Brozovic, M.3
-
17
-
-
0025827323
-
Tissue type plasminogen tivator binds to and is inhibited by surface-bound Lp(a) and LDL
-
Simon DI, Fless GM, Scanu AM, et al: Tissue type plasminogen tivator binds to and is inhibited by surface-bound Lp(a) and LDL. Biochemistry 30:6671-6677, 1991
-
(1991)
Biochemistry
, vol.30
, pp. 6671-6677
-
-
Simon, D.I.1
Fless, G.M.2
Scanu, A.M.3
-
18
-
-
0027195040
-
Fibrinolysis in hypertriglyceridaemic subjects in response to venous occlusion
-
Avellone G, Di Garbo V, Cordova R, et al: Fibrinolysis in hypertriglyceridaemic subjects in response to venous occlusion. Blood Coagul Fibrinol 4:429-433, 1993
-
(1993)
Blood Coagul Fibrinol
, vol.4
, pp. 429-433
-
-
Avellone, G.1
Di Garbo, V.2
Cordova, R.3
-
19
-
-
0022354051
-
Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction
-
Hamsten A, Wiman B, De Faire U, et al: Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction. N Engl J Med 313:1557-1563, 1985
-
(1985)
N Engl J Med
, vol.313
, pp. 1557-1563
-
-
Hamsten, A.1
Wiman, B.2
De Faire, U.3
-
20
-
-
0025970133
-
Evidence for increased levels of plasminogen activator inhibitors and tissue plasminogen activator in plasma in patients with angiographically verified coronary artery disease
-
Olofsson BO, Dahlen G, Nilsson TK: Evidence for increased levels of plasminogen activator inhibitors and tissue plasminogen activator in plasma in patients with angiographically verified coronary artery disease. Eur Heart J 12:157-161, 1991
-
(1991)
Eur Heart J
, vol.12
, pp. 157-161
-
-
Olofsson, B.O.1
Dahlen, G.2
Nilsson, T.K.3
-
21
-
-
0025734531
-
Increased plasma plasminogen activator inhibitor 1 levels. A possible link between insulin resistance and atherogenesis
-
Juhan-Vague I, Alessi MC, Vague P: Increased plasma plasminogen activator inhibitor 1 levels. A possible link between insulin resistance and atherogenesis. Diabetologia 34:457-462, 1991
-
(1991)
Diabetologia
, vol.34
, pp. 457-462
-
-
Juhan-Vague, I.1
Alessi, M.C.2
Vague, P.3
-
22
-
-
0025941333
-
Hyperinsulinemia, sex, and risk of atherosclerotic cardiovascular disease
-
Modan M, Or J, Karasik A, et al: Hyperinsulinemia, sex, and risk of atherosclerotic cardiovascular disease. Circulation 84:1165-1175, 1991
-
(1991)
Circulation
, vol.84
, pp. 1165-1175
-
-
Modan, M.1
Or, J.2
Karasik, A.3
-
23
-
-
0027463873
-
Plasminogen activator inhibitor activity in diabetic and nondiabetic survivors of myocardial infarction
-
Gray RP, Patterson DLH, Yudkin JS: Plasminogen activator inhibitor activity in diabetic and nondiabetic survivors of myocardial infarction. Arterioscler Thromb 13:415-420, 1993
-
(1993)
Arterioscler Thromb
, vol.13
, pp. 415-420
-
-
Gray, R.P.1
Patterson, D.L.H.2
Yudkin, J.S.3
-
24
-
-
0020536979
-
Hypertriglyceridaemia and hypercoagulability
-
Simpson HCR, Meade TW, Stirling Y, et al: Hypertriglyceridaemia and hypercoagulability. Lancet 1:786-790, 1983
-
(1983)
Lancet
, vol.1
, pp. 786-790
-
-
Simpson, H.C.R.1
Meade, T.W.2
Stirling, Y.3
-
25
-
-
0026567090
-
Hypertriglyceridemia and regulation of fibrinolytic activity
-
Mussoni L, Mannucci L, Sirtori M, et al: Hypertriglyceridemia and regulation of fibrinolytic activity. Arterioscler Thromb 12:19-27, 1992
-
(1992)
Arterioscler Thromb
, vol.12
, pp. 19-27
-
-
Mussoni, L.1
Mannucci, L.2
Sirtori, M.3
-
26
-
-
0023801759
-
Association between coagulation factor VII and X with triglyceride rich lipoproteins
-
Carvalho de Sousa J, Soria C, Ayrault-Jarret M, et al: Association between coagulation factor VII and X with triglyceride rich lipoproteins. J Clin Pathol 41:940-944, 1988
-
(1988)
J Clin Pathol
, vol.41
, pp. 940-944
-
-
Carvalho De Sousa, J.1
Soria, C.2
Ayrault-Jarret, M.3
-
27
-
-
0026762721
-
Prospective analysis of the insulin-resistance syndrome (syndrome X)
-
Haffner SM, Valdez RA, Hazuda HP, et al: Prospective analysis of the insulin-resistance syndrome (syndrome X). Diabetes 41:715-722, 1992
-
(1992)
Diabetes
, vol.41
, pp. 715-722
-
-
Haffner, S.M.1
Valdez, R.A.2
Hazuda, H.P.3
-
28
-
-
0027978123
-
Coagulation, lysis and haemorrheology in premenopausal obese women with different body fat distribution
-
Avellone G, Di Garbo V, Cordova R, et al: Coagulation, lysis and haemorrheology in premenopausal obese women with different body fat distribution. Thromb Res 75:223-231, 1994
-
(1994)
Thromb Res
, vol.75
, pp. 223-231
-
-
Avellone, G.1
Di Garbo, V.2
Cordova, R.3
-
29
-
-
0029550047
-
Haemostatic function in young subjects with central obesity: Relationship with left ventricular function
-
Licata G, Scaglione R, Avellone G, et al: Haemostatic function in young subjects with central obesity: Relationship with left ventricular function. Metabolism 44:1417-1421, 1995
-
(1995)
Metabolism
, vol.44
, pp. 1417-1421
-
-
Licata, G.1
Scaglione, R.2
Avellone, G.3
-
30
-
-
0022636643
-
Population correlates of plasma fibrinogen and factor VII, putative cardiovascular risk factors
-
Folsom AR, Wu KK, Davis CE, et al: Population correlates of plasma fibrinogen and factor VII, putative cardiovascular risk factors. Atherosclerosis 59:263-269, 1986
-
(1986)
Atherosclerosis
, vol.59
, pp. 263-269
-
-
Folsom, A.R.1
Wu, K.K.2
Davis, C.E.3
-
31
-
-
0022625882
-
Correlation between blood fibrinolytic activity, plasminogen inhibitor level, plasma insulin level, and relative body weight in normal and obese subjects
-
Vague P, Juhan-Vague I, Allaud MF, et al: Correlation between blood fibrinolytic activity, plasminogen inhibitor level, plasma insulin level, and relative body weight in normal and obese subjects. Metabolism 35:250-253, 1986
-
(1986)
Metabolism
, vol.35
, pp. 250-253
-
-
Vague, P.1
Juhan-Vague, I.2
Allaud, M.F.3
-
32
-
-
0028685826
-
Blood coagulation and fibrinolysis in obese NIDDM patients
-
Avellone G, Di Garbo V, Cordova R, et al: Blood coagulation and fibrinolysis in obese NIDDM patients. Diabetes Res 25:85-92, 1994
-
(1994)
Diabetes Res
, vol.25
, pp. 85-92
-
-
Avellone, G.1
Di Garbo, V.2
Cordova, R.3
-
33
-
-
0028321765
-
Haemostatic abnormalities persist despite glycaemic improvement by insulin therapy in lean type 2 diabetic patients
-
Knobl P, Schenhahaner G, Schnack C, et al: Haemostatic abnormalities persist despite glycaemic improvement by insulin therapy in lean type 2 diabetic patients. Thromb Haemost 71:692-697, 1994
-
(1994)
Thromb Haemost
, vol.71
, pp. 692-697
-
-
Knobl, P.1
Schenhahaner, G.2
Schnack, C.3
-
34
-
-
0030055521
-
Influence of metabolic control on thromboxane biosynthesis and plasma plasminogen activator inhibitor type-1 in non-insulin-dependent diabetes mellitus
-
Davi G, Belvedere M, Vigneri S, et al: Influence of metabolic control on thromboxane biosynthesis and plasma plasminogen activator inhibitor type-1 in non-insulin-dependent diabetes mellitus. Thromb Haemost 76:34-37, 1996
-
(1996)
Thromb Haemost
, vol.76
, pp. 34-37
-
-
Davi, G.1
Belvedere, M.2
Vigneri, S.3
-
35
-
-
0023092605
-
Effectiveness of low-dose heparin in prevention of myocardial reinfarction
-
Neri Serneri GG, Gensini GF, Carnovali M et al: Effectiveness of low-dose heparin in prevention of myocardial reinfarction. Lancet 1:937-942, 1987
-
(1987)
Lancet
, vol.1
, pp. 937-942
-
-
Neri Serneri, G.G.1
Gensini, G.F.2
Carnovali, M.3
-
36
-
-
0024819693
-
Hyperglycemia may determine fibrinopeptide A plasma level increase in humans
-
Ceriello A, Giugliano D, Quatraro A, et al: Hyperglycemia may determine fibrinopeptide A plasma level increase in humans. Metabolism 38:1162-1163, 1989
-
(1989)
Metabolism
, vol.38
, pp. 1162-1163
-
-
Ceriello, A.1
Giugliano, D.2
Quatraro, A.3
-
37
-
-
0028009948
-
Fibrinogen plasma levels as a marker of thrombin activation in diabetes
-
Ceriello A, Taboga C, Giacomello R, et al: Fibrinogen plasma levels as a marker of thrombin activation in diabetes. Diabetes 43:430-432, 1994
-
(1994)
Diabetes
, vol.43
, pp. 430-432
-
-
Ceriello, A.1
Taboga, C.2
Giacomello, R.3
-
38
-
-
0018343895
-
Reduced fibrinogen survival in diabetes mellitus: A reversible phenomenon
-
Jones RL, Peterson CM: Reduced fibrinogen survival in diabetes mellitus: A reversible phenomenon. J Clin Invest 63:485-493, 1979
-
(1979)
J Clin Invest
, vol.63
, pp. 485-493
-
-
Jones, R.L.1
Peterson, C.M.2
|